- Assistant Professor, CWRU School of Medicine
- Acute Leukemia
- Allogenic and Autologous Blood and Bone Marrow Transplantation
Patient Satisfaction Reviews
5.0 out of 5
Patient Comments (9)
Reviewed On 6/1/2020
Dr Metheny and his staff are always caring and very attentive, I am very pleased with them.
Reviewed On 5/1/2020
Dr Metheny and his staff are excellent caregivers.
Reviewed On 3/6/2020
I generally see Dr. Methany every 6 months. I have blood work done before the appointment so the results are discussed at the appointment. He is very good at explaining my results and is able to answer all of my questions. I will continue to see him in the future.
Reviewed On 2/21/2020
Dr. Metheny and his team are wonderful which I greatly value and appreciate. Thank you!
Reviewed On 2/12/2020
Reviewed On 1/7/2020
Great office staff beginning with the front desk staff to the blood tech to the student doctor and finally the physician. it was a great visit from start to finish.
Reviewed On 12/26/2019
This was my first time with this doctor and I was completely comfortable. It was obvious that he had read my information and was very well acquainted with my issues. I look forward to my next visit.
Reviewed On 11/4/2019
excellent staff and excellent doctor
Reviewed On 10/24/2019
dr. was optimistic and helpful. great doctor!
- Hematology - American Board of Internal Medicine
- Internal Medicine - American Board of Internal Medicine
Fellowship | Hematology/Oncology
Hematology/Oncology - Uh Case Medical Center (2012 - 2015)
Residency | Internal Medicine
Internal Medicine - Uh Case Medical Center (2008 - 2012)
Case Western Reserve University School Of Medicine (2008)
Case Western Reserve University (2004)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Leland Metheny did not disclose any Outside Relationships with Industry.